<DOC>
	<DOC>NCT02639650</DOC>
	<brief_summary>This clinical trial is designed to study the effect and safety of paclitaxel plus cisplatin as the first-line regimen in the treatment of high risk gestational trophoblastic tumor.</brief_summary>
	<brief_title>Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor</brief_title>
	<detailed_description />
	<mesh_term>Trophoblastic Neoplasms</mesh_term>
	<mesh_term>Gestational Trophoblastic Disease</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Dactinomycin</mesh_term>
	<criteria>Patients who International Federation of Gynecology and Obstetrics (FIGO) Stage I, II, or III criteria for highrisk gestational trophoblastic neoplasia (GTN) and stage Ⅳ cases World Health Organization(WHO) risk score ≥7 Age≤60 years; female, Chinese women Initial treatment is chemotherapy Performance status: Karnofsky score≥60 Laboratory tests: WBC≥3.5×10(9)/L, ANC≥1.5×10(9)/L, PLT≥80×10(9)/L, serum bilirubin≤ 1.5 times the upper limit of normal, transaminase≤ 1.5 times the upper limit of normal,blood urea nitrogen, Cr≤ normal Provide written informed consent. Patients with unconfirmed diagnosis of GTN Patients with placentalsite trophoblastic tumor (PSTT) or epithelioid trophoblastic tumor (ETT) WHO risk score 《7 With severe or uncontrolled internal disease, unable to receive chemotherapy Concurrently participating in other clinical trials Unable or unwilling to sign informed consents Unable or unwilling to abide by protocol</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>gestational trophoblastic tumor</keyword>
	<keyword>paclitaxel</keyword>
	<keyword>cisplatin</keyword>
	<keyword>carboplatin</keyword>
	<keyword>chemotherapy</keyword>
</DOC>